Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 9Elaprase
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 77
2021 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2019 Revenue in Millions : 627
2018 Revenue in Millions : 0
Growth (%) : N/A
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2020 Revenue in Millions : 637
2019 Revenue in Millions : 640
Growth (%) : 0
Main Therapeutic Indication : Metabolic Disorders
Currency : USD
2021 Revenue in Millions : 633
2020 Revenue in Millions : 611
Growth (%) : 12
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 620
2021 Revenue in Millions : 633
Growth (%) : -2
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 616
2022 Revenue in Millions : 620
Growth (%) : 12
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2024 Revenue in Millions : 673
2023 Revenue in Millions : 613
Growth (%) : 10
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2016 Revenue in Millions : 589
2015 Revenue in Millions : 553
Growth (%) : 7
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 615
2016 Revenue in Millions : 589
Growth (%) : 4
